SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-026039
Filing Date
2019-12-12
Accepted
2019-12-12 17:27:53
Documents
4
Period of Report
2019-12-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k120919_tengjunbiotech.htm 8-K 25629
2 AMENDMENT OF ARTICLES OF INCORPORATION DATED NOVEMBER 25, 2019 f8k120919ex3-1_tengjun.htm EX-3.1 1359
3 GRAPHIC ex3-1_001.jpg GRAPHIC 402216
4 GRAPHIC ex3-1_002.jpg GRAPHIC 468062
  Complete submission text file 0001213900-19-026039.txt   1227018
Mailing Address FL 4 AIRPORT INDUSTRIAL PARK BIZ CENTER NO.35 CHANGJIANG SOUTH ROAD, NEW DIST. WUXI F4 214028
Business Address FL 4 AIRPORT INDUSTRIAL PARK BIZ CENTER NO.35 CHANGJIANG SOUTH ROAD, NEW DIST. WUXI F4 214028 8613909840703
Tengjun Biotechnology Corp. (Filer) CIK: 0001499785 (see all company filings)

IRS No.: 273042462 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-169397 | Film No.: 191282701
SIC: 4832 Radio Broadcasting Stations